Patent classifications
C
C07
C07D
265/00
C07D265/04
C07D265/04
Bicyclic peptide-toxin conjugates specific for MT1-MMP
The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.
Bicyclic peptide-toxin conjugates specific for MT1-MMP
The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.
BICYCLIC PEPTIDE-TOXIN CONJUGATES SPECIFIC FOR MT1-MMP
The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.